{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:06Z","timestamp":1790803266443,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.clinthera.2021.08.007","type":"journal-article","created":{"date-parts":[[2021,10,2]],"date-time":"2021-10-02T06:57:15Z","timestamp":1633157835000},"page":"1638-1644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years"],"prefix":"10.1016","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7094-2322","authenticated-orcid":false,"given":"Christopher R.","family":"Piszczatoski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2021.08.007_bib0001","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMcp1702493","article-title":"Acne vulgaris","volume":"379","author":"Zaenglein","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinthera.2021.08.007_bib0002","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mehy.2017.08.016","article-title":"Use of polymethylmethacrylate (PMMA) microspheres collagen to treat atrophic acne scars","volume":"108","author":"Ng","year":"2017","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.clinthera.2021.08.007_bib0003","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clinthera.2021.08.007_bib0004","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.13786","article-title":"Cumulative mental health consequences of acne: 23-year follow-up in a general population birth cohort study","author":"Ramrakha","year":"2016","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.clinthera.2021.08.007_bib0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s40168-018-0558-5","article-title":"Host-microbiome interactions and recent progress into understanding the biology of acne vulgaris","volume":"6","author":"O'Neill","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.clinthera.2021.08.007_bib0006","unstructured":"InformedHealth.org [Internet]. Cologne, Germany: Institute for Quality and Efficiency in Health Care (IQWiG); 2006. Acne: Overview. 2013 Jan 16 [Updated 2019 Sep 26]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK279211\/."},{"key":"10.1016\/j.clinthera.2021.08.007_bib0007","unstructured":"Elliot W. Clascoterone cream 1% (Winlevi\u00ae) [Internet]. 2020 [cited 2021Feb25]. Available from: https:\/\/www.reliasmedia.com\/articles\/146948-clascoterone-cream-1-winlevi."},{"key":"10.1016\/j.clinthera.2021.08.007_bib0008","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00266-006-0081-0","article-title":"Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians","volume":"30","author":"Sato","year":"2006","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.clinthera.2021.08.007_bib0009","unstructured":"Winlevi\u00ae (clascoterone) [package Insert]. Lainate, Italy: Cassiopea, Inc; 2020."},{"key":"10.1016\/j.clinthera.2021.08.007_bib0010","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1001\/jamadermatol.2020.0465","article-title":"Efficacy and safety of topical clascoterone cream, 1%, for treatment in patients with facial acne: two phase 3 randomized clinical trials","volume":"156","author":"Hebert","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clinthera.2021.08.007_bib0011","unstructured":"Prescription price comparison: compare drug prices [Internet]. 2021 [cited 2021Mar5]. Available from: https:\/\/www.wellrx.com\/prescriptions\/WINLEVI\/."},{"key":"10.1016\/j.clinthera.2021.08.007_bib0012","unstructured":"Blink Health Online Pharmacy & Discount Prescriptions. Blink Health; 2021 [cited 2021Mar5]. Available from: https:\/\/www.blinkhealth.com\/winlevi."},{"key":"10.1016\/j.clinthera.2021.08.007_bib0013","unstructured":"Winlevi prices and discount coupons [Internet]. America's Pharmacy. America's Pharmacy; 2021 [cited 2021Mar5]. Available from: https:\/\/www.americaspharmacy.com\/drug\/winlevi."}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821003064?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291821003064?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:56:38Z","timestamp":1758963398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291821003064"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0149291821003064"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.08.007","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Topical Clascoterone: The First Novel Agent for Acne Vulgaris in 40 Years","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2021.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}